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Abstract 
Background. Patients with degenerative aortic stenosis (AS) exhibit elevated prevalence of 
coronary artery disease (CAD) and internal carotid artery stenosis (ICAS). Our aim was to in-
vestigate prevalence of significant CAD and ICAS in relation to demographic and cardiovascular 
risk profile among patients with severe degenerative AS. 
Methods. We studied 145 consecutive patients (77 men and 68 women) aged 49–91 years 
(median, 76) with severe degenerative AS who underwent coronary angiography and carotid ul-
trasonography in our tertiary care center. The patients were divided into two groups according to 
the presence of either significant CAD (n=86) or ICAS (n=22).  
Results. The prevalence of significant CAD or ICAS was higher with increasing number of tra-
ditional risk factors (hypertension, hypercholesterolemia, diabetes, smoking habit) and decreasing 
renal function. We found interactions between age and gender in terms of CAD (p=0.01) and ICAS 
(p=0.06), which was confirmed by multivariate approach. With the reference to men with a be-
low-median age, the prevalence of CAD or ICAS increased in men aged >76 years (89% vs. 55% 
and 28% vs. 14%, respectively), whereas the respective percentages were lower in older vs. 
younger women (48% vs. 54% and 7% vs. 17%).  
Conclusions. In severe degenerative AS gender modulates the association of age with coronary 
and carotid atherosclerosis with its lower prevalence in women aged >76 years compared to their 
younger counterparts. This may result from a hypothetical “survival bias”, i.e., an excessive risk of 
death in very elderly women with severe AS and coexisting relevant coronary or carotid ather-
osclerosis. 
Key words: degenerative aortic stenosis; coronary artery disease; carotid atherosclerosis; elderly; 
gender. 
Introduction 
Non-rheumatic degenerative aortic stenosis is 
the most frequent type of acquired valvular heart 
disease in Europe and North America and its preva-
lence averages from 2% to 7% in people above 65 
years of age [1-4]. Degenerative aortic stenosis and 
coronary artery disease (CAD) share many similari-
ties, being chronic, gradually progressive inflamma-
tory disorders. Traditional cardiovascular risk factors 
are associated with the development of both these 








only 40% of patients with severe aortic stenosis have 
significant CAD and aortic stenosis is absent in the 
majority of CAD patients, which suggests different 
pathogenesis of these diseases [8,9]. Additionally, the 
prevalence of internal carotid artery stenosis (ICAS) 
≥50% in patients with degenerative aortic stenosis was 
higher in subjects with coexisting CAD [10].  
 There is a paucity of reports on determinants of 
both coronary and carotid atherosclerosis in patients 
with degenerative aortic stenosis. Our aim was to 
investigate the prevalence of coronary and internal 
carotid atherosclerosis in relation to demographic and 
cardiovascular risk profile among patients with se-
vere degenerative aortic stenosis undergoing diag-
nostic coronary angiography and carotid ultrasonog-
raphy in our center. 
Patients and Methods 
 We retrospectively collected data on 145 con-
secutive patients with severe degenerative aortic ste-
nosis who were admitted to our tertiary care center 
between January 2003 and October 2012 and under-
went elective coronary angiography and carotid ul-
trasonography during the index hospitalization. The 
diagnosis of aortic stenosis was confirmed by trans-
thoracic echocardiography. Patients with a 
non-degenerative etiology of aortic stenosis and sub-
jects with bicuspid or unicuspid aortic valve were 
excluded from the registry. Coronary angiography 
was performed as a part of a standard diagnostic 
procedure on the basis of classical indications: before 
elective aortic valve replacement and/or due to 
symptoms suggestive of myocardial ischemia. De-
mographic and clinical data, including traditional risk 
factors (arterial hypertension, hypercholesterolemia, 
diabetes mellitus, smoking) and past medical history 
(cerebrovascular incident, coronary revascularization) 
were registered. Biochemical data included serum 
creatinine, total cholesterol, low-density lipoprotein 
cholesterol (LDL-C), high-density lipoprotein choles-
terol (HDL-C) and triglycerides measured after an 
overnight fast during the index hospitalization. Esti-
mated glomerular filtration rate (eGFR) was calcu-
lated by the simplified equation developed by the 
Modification of Diet in Renal Disease (MDRD) Study 
Group [11]. The ethics committee of our university 
was notified about the registry and no objection was 
raised.  
 All patients underwent transthoracic echocar-
diography during index hospitalization. We recorded 
mean and maximal transaortic valve pressure gradi-
ents, left ventricular ejection fraction; aortic valve area 
(AVA) was estimated by means of the continuity 
equation. Severe aortic stenosis in echocardiography 
was defined as a mean transaortic gradient >40 
mmHg or a calculated AVA <1.0 cm2.  
 Coronary angiography was performed by a 
standard protocol with a transfemoral or transradial 
approach and obstructive CAD was defined as the 
presence of ≥1 diameter stenosis of ≥50% of at least 
one major epicardial coronary artery. Carotid arteries 
were visualized by B-mode imaging using a 
high-resolution ultrasound device equipped with a 
4.0–10.0-MHz vascular transducer (GE Vivid 7; GE 
Healthcare, Chalfont St. Giles, UK). Cardiovascular 
risk factors were defined as follows: 
- arterial hypertension: systolic pressure ≥140 
mmHg and/or diastolic pressure ≥90 mmHg in at 
least 2 measurements or blood pressure requiring 
medical therapy during index hospitalization or an-
tihypertensive medication prior to admission; 
- hypercholesterolemia: fasting total cholesterol 
>5.2 mmol/l during index hospitalization or diag-
nosed previously and/or medically treated; 
- diabetes mellitus: fasting venous plasma glu-
cose ≥7 mmol/l confirmed by repeated testing or 
casual plasma glucose ≥11.1 mmol/l during index 
hospitalization or diagnosis established before ad-
mission; 
- smoking: self-reported regular smoking habit. 
Statistical analysis 
 Continuous variables were presented as mean 
and standard deviation (SD) or median and range. 
The accordance with a normal distribution was con-
firmed by the Kolmogorov-Smirnov test. Categorical 
data were shown as numbers and percentages.  
 The patients were divided into 2 groups ac-
cording to the prevalence of significant CAD or rele-
vant internal carotid artery stenosis (ICAS). Signifi-
cant CAD was defined as obstructive CAD (according 
to the above mentioned criterion) or a history of cor-
onary artery bypass grafting or percutaneous coro-
nary intervention. Relevant ICAS corresponded to a 
stenosis of ≥50% in at least one internal carotid artery. 
Intergroup differences were calculated by a 2-sided 
Student’s t test or the Mann-Whitney’s U test for con-
tinuous data and the chi2 test or Fisher’s exact test for 
proportions.  
 Patients’ characteristics related to the prevalence 
of significant CAD or relevant ICAS were identified 
by logistic regression and odds ratios (OR) with 95% 
confidence intervals (CI) for predictor variables have 
been shown. OR represents a multiplicative rise in the 
odds of a patient having significant CAD or relevant 
ICAS associated with a change in the explanatory 
variable. In case of continuous variables, OR is calcu-
lated for each one-unit increment in the predictor 
variable, whereas OR for dichotomous categorical 
data reflects an increase in the odds of prevalent CAD 




or ICAS in the patients exposed to a factor of interest 
compared to a reference group without this exposure.  
 As preliminary data analysis indicated that the 
effect of age on the prevalence of CAD or ICAS could 
be modified by gender, we created an interaction term 
that was set to 1 in women with an over-median age 
(>76 years) being equal to 0 in the remainder study 
subjects. In order to evaluate the interaction, the in-
teraction term was entered into the regression model 
in addition to age and gender. Additionally, the in-
teraction was depicted by calculating OR of CAD 
prevalence for 3 subgroups of subjects created ac-
cording to gender and age with the reference to 
women aged >76 years. This latter approach was not 
applied for ICAS because of a small number of sub-
jects with this condition (n=22). 
 Independent predictors of the prevalence of 
relevant CAD or ICAS were identified by multiple 
logistic regression with backward stepwise variable 
selection. When building the model, the values of 
p-to-enter and p-to-remove were set at 0.10 and 0.15, 
respectively. The goodness-of-fit of the final regres-
sion equation was confirmed by the Hos-
mer-Lemeshow test. A p-value <0.05 was inferred 
significant. 
Results 
 The registry encompassed data of 145 patients 
(77 men, 53%) aged 49–91 years (mean 75 ± 9 years). 
The women enrolled to the registry were significantly 
older than men (77.4 ± 9.1 vs. 72.2 ± 9.0 years, 
p<0.001).  
 Patients’ characteristics by the presence of CAD 
or ICAS have been presented in Table 1 and Table 2, 
respectively. The occurrence of ICAS and CAD was 
independent of each other (Tables 1-2). The subjects 
with significant CAD were more frequently men, ex-
hibited lower eGFR, and tended to be older compared 
to those without CAD (Table 1). Reduced transaortic 
valve pressure gradients and decreased left ventricu-
lar ejection fraction despite a similar AVA in CAD 
patients were presumably due to a history of myo-
cardial infarction in the majority of this subgroup 
(63%) (Table 1). A tendency to lower eGFR was ob-
served in the patients with relevant ICAS with the 
reference to their counterparts (Table 2). These inter-
group differences were reflected by analogous results 
of univariate logistic regression (Tables 3-4). With 
regard to traditional risk factors, the occurrence of 
hypercholesterolemia or diabetes was higher in the 
subjects with CAD or ICAS, respectively, versus their 
counterparts, whereas insignificant tendencies were 
observed for hypertension and diabetes for CAD and 
hypercholesterolemia for ICAS (Table 1). As the rela-
tions between individual traditional risk factors and 
CAD or ICAS were unidirectional irrespective of the 
degree of statistical significance, the number of clas-
sical risk factors was entered into logistic regression as 
one variable, which revealed the association between 
risk factors clustering and an increased prevalence of 
CAD (Table 3) and ICAS (Table 4).  
 The effect of age on the prevalence of CAD and 
ICAS was different in men and women. With the ref-
erence to men with a below-median age (≤76 years), 
the prevalence of CAD increased in men aged over 76 
years (by about 60%: 89% vs. 55%), which was not 
observed in women. Furthermore, the percentage of 
subjects with CAD was even slightly lower in women 
aged >76 years compared to women aged ≤76 years 
(48% vs. 54%) (Table 5). A similar pattern was ob-
served for respective proportions of patients with 
ICAS, being 2-fold higher in men with an 
over-median age with the reference to those with a 
below-median age (28 vs. 14%), but over 2-fold lower 
in older versus younger women (7% vs. 17%) (Table 
5).  
 By logistic regression analysis, the interactions 
between age and gender were confirmed by a signif-
icant effect of the age-gender interaction term on CAD 
prevalence (OR, 0.58 [95% CI, 0.38–0.88], p=0.01), 
which was equivalent to a decrease in the odds of 
prevalent CAD in women with an over-median age. 
An analogous association was observed for the pro-
portion of ICAS, albeit slightly below the level of sta-
tistical significance (OR, 0.63 [0.38–1.02], p=0.06 for the 
interaction term). With the reference to women aged 
>76 years, OR of CAD prevalence was significantly 
increased in men aged >76 years (OR, 3.03 [1.55–5.92], 
p=0.001), being only slightly higher in younger 
women (OR, 1.14 [0.69–1.89], p=0.61) and younger 
men (OR, 1.16 [0.77–1.74], p=0.48).  
The strength of these interactions was main-
tained after multivariate adjustment (CAD: OR, 0.54 
[0.35–0.84], p=0.006; ICAS: 0.60 [0.35–1.02], p=0.06 for 
the age-gender interaction term). In addition to the 
interaction term, the following covariates were re-
tained in final equations by backward stepwise lo-
gistic regression analysis: the number of risk factors 
(CAD: OR per increment of one, 2.15 [1.33–3.46], 
p=0.002; ICAS: OR, 2.47 [1.33–4.57], p=0.004), eGFR 
(CAD: OR per rise of 10 ml/min per 1.73 m2, 0.81 
[0.70–0.95], p=0.007) and female gender (CAD: OR, 
0.71 [0.47–1.06], p=0.09; ICAS: OR, 0.59 [0.33–1.05], 
p=0.07). The goodness-of-fit of the final regression 
models for the prevalence of CAD and ICAS was 
validated (p=0.91 and 0.58, respectively, by the Hos-
mer-Lemeshow test). 
 




Table 1. Patients’ characteristics by the presence of significant CAD. 
 No CAD CAD  
 (n=59) (n=86) p-value 
Demographics 
Age, years 73 ± 10 76 ± 9 0.10 
Male sex 26 (44.1%) 53 (61.6%) 0.04 
Medical history 
Arterial hypertension 46 (78.0%) 76 (88.4%) 0.09 
Hypercholesterolemia 33 (55.9%) 64 (74.4%) 0.02 
Diabetes mellitus 17 (28.8%) 35 (40.7%) 0.14 
Smoking 5 (8.5%) 10 (11.6%) 0.44 
Cerebrovascular event (TIA or stroke) 7 (11.9%) 8 (9.3%) 0.62 
Previous CABG - 11 (12.8%)  
Previous percutaneous coronary intervention - 38 (44.2%)  
Previous myocardial infarction - 54 (62.8%)  
Echocardiographic parameters 
Left ventricular EF, % (median [range]) 65 [20–84] 56 [20–75] <0.0001 
PG-max., mmHg 104 ± 26 80 ± 25 <0.0001 
PG-mean, mmHg 65 ± 19 49 ± 17 <0.0001 
AVA, cm2 (median [range]) 0.7 [0.3–1.0] 0.7 [0.3–1.0] 0.11 
Carotid ultrasound 
Relevant ICAS (≥50%) 7 (11.9%) 15(17.4%) 0.36 
Biochemical parameters 
Total cholesterol, mmol/l 4.5 ± 1.1 4.5 ± 1.1 0.83 
LDL-C, mmol/l 2.4 ± 1.1 2.6 ± 0.8 0.56 
HDL-C, mmol/l 1.5 ± 0.4 1.3 ± 0.4 0.07 
Triglycerides, mmol/l 1.2 ± 0.5 1.4 ± 0.9 0.17 
eGFR, ml/min per 1.73 m2 85.8 ± 26.4 71.9 ± 29.4 0.007 
Categorical data are shown as n (%) and continuous data as mean ± SD unless stated otherwise. CAD: coronary artery disease; TIA: transient ischemic attack; 
CABG: coronary artery bypass grafting; EF: ejection fraction; PG- max.: maximal transaortic valve pressure gradient; PG-mean: mean transaortic valve pressure 
gradient; AVA: aortic valve area; ICAS: internal carotid artery stenosis; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; 
eGFR: estimated glomerular filtration rate. 
Table 2. Patients’ characteristics by the presence of relevant internal carotid artery stenosis (ICAS). 
 No ICAS ICAS  
 (n=123) (n=22) p-value 
Demographics 
Age, years 75 ± 10 74 ± 8  0.92 
Male sex 64 (52.0%) 15 (68.2%) 0.17 
Medical history 
Arterial hypertension 102 (82.9%) 20 (90.9%) 0.53 
Hypercholesterolemia 79 (64.2%) 18 (81.8%) 0.14 
Diabetes mellitus 39 (31.7%) 13 (59.1%) 0.02 
Smoking 11 (8.9%) 4 (18.2%) 0.25 
Cerebrovascular event (TIA or stroke) 13 (10.6%) 2 (9.1%) 1.00 
Previous CABG 9 (7.3%) 2 (9.1%) 0.67 
Previous percutaneous coronary intervention 30 (24.4%) 8 (36.4%) 0.29 
Echocardiographic parameters 
Left ventricular EF, % (median [range]) 60 [20–84] 60 [30–73] 0.71 
PG-max., mmHg 90 ± 27 88 ± 33 0.77 
PG-mean, mmHg 56 ± 19 51 ± 20 0.24 
AVA, cm2 (median [range])  0.7 [0.3–1.0] 0.8 [0.6–1.0] 0.38 
Coronary angiography 
Obstructive CAD 71 (57.7%) 15 (68.2%) 0.36 
Biochemical parameters 
Total cholesterol, mmol/l 4.5 ± 1.1 4.1 ± 0.9 0.39 
LDL-C, mmol/l  2.5 ± 1.0 2.4 ± 0.9 0.74 
HDL-C, mmol/l  1.4 ± 0.4 1.2 ± 0.2 0.22 
Triglycerides, mmol/l  1.3 ± 0.8 1.2 ± 0.4 0.68 
eGFR, ml/min per 1.73 m2 79.3 ± 27.8 68.1 ± 34.3 0.11 
Categorical data are shown as n (%) and continuous data as mean ± SD unless stated otherwise. Abbreviations as in Table 1. 




Table 3. Univariate logistic regression analysis of predictors of the prevalence of significant coronary artery disease (CAD) in patients 
with severe aortic stenosis. 
Predictor variable  Odds ratio (OR) of prevalent CAD 
Wald statistic Mean OR (95% CI) p-value 
Gender (women vs. men) 4.30 0.70 (0.50–0.98) 0.04 
Age (per 10-year increment) 2.75 1.35 (0.95–1.94) 0.10 
Number of risk factors (per increment of 1) 7.91 1.76 (1.19–2.61) 0.005 
eGFR (per rise of 10 ml/min per 1.73 m2) 7.21 0.84 (0.73–0.95) 0.007 
Aortic valve area (per 0.1 cm2 increment) 3.13 1.20 (0.98–1.47) 0.08  
CI: confidence interval; eGFR: estimated glomerular filtration rate. 
 
Table 4. Univariate logistic regression analysis of predictors of the prevalence of relevant internal carotid artery stenosis (ICAS) in 
patients with severe aortic stenosis. 
Predictor variable  Odds ratio (OR) of prevalent ICAS 
Wald statistic Mean OR (95% CI) p-value 
Gender (women vs. men) 1.91 0.71 (0.44–1.15) 0.17 
Age (per 10-year increment) 0.01 0.98 (0.60–1.58) 0.92 
Number of risk factors (per increment of 1) 8.19 2.32 (1.30–4.12) 0.004 
eGFR (per rise of 10 ml/min per 1.73 m2) 2.54 0.87 (0.74–1.03) 0.11 
Aortic valve area (per 0.1 cm2 increment) 0.84 1.14 (0.86–1.49) 0.36 
Abbreviations as in Table 3. 
 
Table 5. Prevalence of significant CAD and relevant ICAS in relation to age and gender of patients with severe aortic stenosis. 
Gender Age with respect to the median (76 years) 
≤76 years >76 years 
 Prevalence of significant CAD 
Men (n=79) 28 (55%)  25 (89%)* 
Women (n=66) 13 (54%) 20 (48%) 
 Prevalence of relevant ICAS 
Men (n=79) 7 (14%) 8 (28%)† 
Women (n=66) 4 (17%) 3 (7%) 
Data are shown as numbers (%). CAD: coronary artery disease; ICAS: internal carotid artery stenosis. 
*p = 0.0003 vs. women >76 years, p = 0.006 vs. women ≤76 years and p = 0.002 vs. men ≤76 years; †p = 0.02 vs. women >76 years by the 2-tailed Fisher’s exact test. 
 
Discussion 
 Our salient finding was a significant effect of 
gender on the relation between age and the preva-
lence of angiographic CAD in patients with severe 
degenerative aortic stenosis. In contrast to men, the 
prevalence of CAD did not increase in women aged 
over 76 years compared to women with a be-
low-median age (≤76 years), being even slightly low-
er. The age-gender interaction in terms of CAD ap-
pears counterintuitive because the prevalence of an-
giographic CAD increases with age in men and 
women [12]. That this interaction retained statistical 
significance after adjustment for atherosclerotic risk 
factors and tended to be present – albeit slightly be-
low the level of statistical significance – for relevant 
ICAS, suggests an underlying mechanism related to 
the severity of atherosclerosis, yet other than a dif-
ferent risk profile. A hypothetical explanation for the 
differential association of CAD and ICAS with age in 
men and women may be a “survival bias”. According 
to this concept, women who suffered from both severe 
aortic stenosis and relevant coronary or internal ca-
rotid atherosclerosis could have been exposed to an 
excessive risk of death due to coronary or cerebro-
vascular events, which might have abolished the 
age-dependent increase in the prevalence of CAD and 
ICAS in women with aortic stenosis. The limitation of 
the hypothetical effect to women with aortic stenosis 
and coexisting CAD or ICAS is consistent with an 
almost 2-fold higher percentage of women as a whole 
among our patients with an over-median age, in 
agreement with a 9-year higher average length of life 
for women compared to men in our country (80.9 vs. 
72.4 years) [13].  
 We observed a joint contribution of recognized 
atherosclerotic risk factors to the development of 
coronary and carotid atherosclerosis in patients with 
severe degenerative aortic stenosis, which confirms 
earlier observations. Kabłak-Ziembicka et al. reported 
a higher percentage of diabetes and smoking habit in 
subjects with degenerative aortic stenosis and con-
comitant ICAS, however, they also described an in-




dependent effect of coexistent CAD on ICAS, which 
was not found in the present study [10]. A possible 
explanation of this inconsistency could be different 
patients’ characteristics because they included 104 
subjects aged 63 ± 8 years with moderate-to-severe 
aortic stenosis [10]. Ortlepp et al. performed an angi-
ographic case–control study in which 523 patients 
referred for elective diagnostic left heart catheteriza-
tion because of severe aortic stenosis were compared 
to controls pair-matched for age, sex and CAD prev-
alence [14]. In patients with severe aortic stenosis the 
number of established risk factors predicted the 
presence of CAD, similar to our data, nevertheless, in 
the absence of CAD none of the risk factors was sig-
nificantly more frequent in aortic stenosis compared 
to those with a normal aortic valve [14]. This finding 
precipitated the conclusion that classical cardiovas-
cular risk factors could be associated with degenera-
tive aortic stenosis purely on the basis of its associa-
tion with CAD [14], which appears in disagreement 
with earlier suggestions that degenerative aortic valve 
disease was associated with similar factors to athero-
sclerotic risk factors as demonstrated in 5,201 subjects 
aged ≥65 years enrolled in the Cardiovascular Health 
Study [6]. Unfortunately, as we analyzed only data of 
patients with aortic stenosis, our study is not able to 
clarify this controversy. On the other hand, Goland et 
al. [15] observed a significantly increased prevalence 
of hypercholesterolemia in 45 subjects aged 75 ± 10 
years with isolated severe degenerative aortic stenosis 
without angiographic CAD compared to 54 sex- and 
age-matched controls without aortic stenosis or CAD. 
Therefore, further investigations are required to iden-
tify additional factors which protect against the de-
velopment of degenerative aortic stenosis despite the 
presence of atherosclerotic risk factors.  
Study limitations 
 First, this was a retrospective, non-blinded ob-
servational study in a relatively low number of sub-
jects and all data were collected from discharge letters 
and hospital records as source documentation. Due to 
a retrospective study design, the final dataset might 
have been incomplete, although we made every effort 
to ensure that all consecutive patients meeting the 
inclusion criteria had been included into the registry. 
Second, the progress in resolution and quality of ul-
trasound imaging over past 10 years could have in-
fluenced the precision of the measurements, none-
theless, cardiac and carotid ultrasound were per-
formed by experienced sonographers. Third, eGFR 
was calculated from the highest level of serum creati-
nine measured during the index hospitalization, nev-
ertheless, time points of blood sampling were not 
standardized. Finally, the evaluation of coronary and 
carotid stenoses was based mostly on visual assess-
ment and a quantitative analysis was not performed 
by an independent core laboratory. 
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